{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:38:15Z","timestamp":1776112695595,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T00:00:00Z","timestamp":1603497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10014-020-00383-x","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T11:02:34Z","timestamp":1603537354000},"page":"59-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic characterization of an aggressive optic nerve pilocytic glioma"],"prefix":"10.1007","volume":"38","author":[{"given":"Christopher S.","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Fliney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeniyi","family":"Fisayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi P.","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Omuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renelle","family":"Pointdujour-Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Zeynep","family":"Erson-Omay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Bulent","family":"Omay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,24]]},"reference":[{"issue":"12","key":"383_CR1","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jocn.2011.09.003","volume":"18","author":"J Shapey","year":"2011","unstructured":"Shapey J, Danesh-Meyer HV, Kaye AH (2011) Diagnosis and management of optic nerve glioma. J Clin Neurosci 18(12):1585\u20131591","journal-title":"J Clin Neurosci"},{"issue":"2","key":"383_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/WNO.0b013e3181e1f85c","volume":"30","author":"J Pasol","year":"2010","unstructured":"Pasol J, Sternau L, Luetmer P, Giannini C (2010) Rapid progressive unilateral visual loss in an elderly man. J Neuroophthalmol 30(2):188\u2013192","journal-title":"J Neuroophthalmol"},{"issue":"6","key":"383_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/01658107.2014.966851","volume":"38","author":"G Bilgin","year":"2014","unstructured":"Bilgin G, Al-Obailan M, Bonelli L, Glasgow BJ, Vinters HV, Arnold AC (2014) Aggressive low-grade optic nerve glioma in adults. Neuroophthalmology 38(6):297\u2013309","journal-title":"Neuroophthalmology"},{"issue":"5","key":"383_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/ICU.0000000000000587","volume":"30","author":"MK Farazdaghi","year":"2019","unstructured":"Farazdaghi MK, Katowitz WR, Avery RA (2019) Current treatment of optic nerve gliomas. Curr Opin Ophthalmol 30(5):356\u2013363","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"383_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40478-020-00898-6","volume":"8","author":"TA Bale","year":"2020","unstructured":"Bale TA (2020) FGFR- gene family alterations in low-grade neuroepithelial tumors. Acta Neuropathol Commun 8(1):21","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"383_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI43690","volume":"121","author":"KW Liu","year":"2011","unstructured":"Liu KW, Feng H, Bachoo R et al (2011) SHP-2\/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A\/ARF aberrations in mice and humans. J Clin Invest 121(3):905\u2013917","journal-title":"J Clin Invest"},{"issue":"5","key":"383_CR7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/cge.13703","volume":"97","author":"AJ Kundishora","year":"2020","unstructured":"Kundishora AJ, Reeves BC, Nelson-Williams C et al (2020) Novel EWSR1-VGLL1 fusion in a pediatric neuroepithelial neoplasm. Clin Genet 97(5):791\u2013792","journal-title":"Clin Genet"},{"issue":"5","key":"383_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0039-6257(94)90173-2","volume":"38","author":"JJ Dutton","year":"1994","unstructured":"Dutton JJ (1994) Gliomas of the anterior visual pathway. Surv Ophthalmol 38(5):427\u2013452","journal-title":"Surv Ophthalmol"},{"key":"383_CR9","first-page":"6","volume":"2","author":"AA Campbell","year":"2019","unstructured":"Campbell AA, Gartrell-Corrado RD, Mansukhani M et al (2019) SETD2 mutation in an aggressive optic nerve glioma. JAMA Ophthalmol 2:6\u201310","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"383_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98\u2013110","journal-title":"Cancer Cell"},{"issue":"31","key":"383_CR11","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1038\/sj.onc.1202829","volume":"18","author":"DH Gutmann","year":"1999","unstructured":"Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A (1999) Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 18(31):4450\u20134459","journal-title":"Oncogene"},{"issue":"5","key":"383_CR12","first-page":"1106","volume":"63","author":"H Ding","year":"2003","unstructured":"Ding H, Shannon P, Lau N et al (2003) Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Res 63(5):1106\u20131113","journal-title":"Cancer Res"},{"issue":"1","key":"383_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40246-017-0109-3","volume":"11","author":"C Philpott","year":"2017","unstructured":"Philpott C, Tovell H, Frayling IM, Cooper DN, Upadhyaya M (2017) The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics 11(1):13","journal-title":"Hum Genomics"},{"issue":"2","key":"383_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11060-019-03306-9","volume":"145","author":"E Trisolini","year":"2019","unstructured":"Trisolini E, Wardighi DE, Giry M et al (2019) Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas. J Neurooncol 145(2):241\u2013245","journal-title":"J Neurooncol"},{"issue":"7","key":"383_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.3590","volume":"48","author":"J Wang","year":"2016","unstructured":"Wang J, Cazzato E, Ladewig E et al (2016) Clonal evolution of glioblastoma under therapy. Nat Genet 48(7):768\u2013776","journal-title":"Nat Genet"},{"issue":"6","key":"383_CR16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/pbc.25382","volume":"62","author":"S Nair","year":"2015","unstructured":"Nair S, Fort JA, Yachnis AT, Williams CA (2015) Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome. Pediatr Blood Cancer 62(6):1084\u20131086","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"383_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/499925","volume":"78","author":"M Tartaglia","year":"2006","unstructured":"Tartaglia M, Martinelli S, Stella L et al (2006) Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 78(2):279\u2013290","journal-title":"Am J Hum Genet"},{"key":"383_CR18","doi-asserted-by":"publisher","first-page":"103875","DOI":"10.1016\/j.bioorg.2020.103875","volume":"100","author":"WS Liu","year":"2020","unstructured":"Liu WS, Yang B, Wang RR et al (2020) Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors. Bioorg Chem 100:103875","journal-title":"Bioorg Chem"},{"issue":"7610","key":"383_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nature18621","volume":"535","author":"YN Chen","year":"2016","unstructured":"Chen YN, LaMarche MJ, Chan HM et al (2016) Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature 535(7610):148\u2013152","journal-title":"Nature"},{"issue":"5","key":"383_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","volume":"86","author":"RJ Packer","year":"1997","unstructured":"Packer RJ, Ater J, Allen J et al (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86(5):747\u2013754","journal-title":"J Neurosurg"},{"issue":"20","key":"383_CR21","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1200\/JCO.2002.08.087","volume":"20","author":"M Massimino","year":"2002","unstructured":"Massimino M, Spreafico F, Cefalo G et al (2002) High response rate to cisplatin\/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20(20):4209\u20134216","journal-title":"J Clin Oncol"},{"issue":"2","key":"383_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1215\/15228517-2006-030","volume":"9","author":"S Gururangan","year":"2007","unstructured":"Gururangan S, Fisher MJ, Allen JC et al (2007) Temozolomide in children with progressive low-grade glioma. Neuro Oncol 9(2):161\u2013168","journal-title":"Neuro Oncol"},{"key":"383_CR23","first-page":"1","volume":"13","author":"ET Hidalgo","year":"2019","unstructured":"Hidalgo ET, Kvint S, Orillac C et al (2019) Long-term clinical and visual outcomes after surgical resection of pediatric pilocytic\/pilomyxoid optic pathway gliomas. J Neurosurg Pediatr 13:1\u20138","journal-title":"J Neurosurg Pediatr"},{"issue":"4","key":"383_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1148\/66.4.518","volume":"66","author":"JM Taveras","year":"1956","unstructured":"Taveras JM, Mount LA, Wood EH (1956) The value of radiation therapy in the management of glioma of the optic nerves and chiasm. Radiology 66(4):518\u2013528","journal-title":"Radiology"},{"issue":"5","key":"383_CR25","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/1097-0142(197711)40:5<2079::AID-CNCR2820400514>3.0.CO;2-4","volume":"40","author":"AB Montgomery","year":"1977","unstructured":"Montgomery AB, Griffin T, Parker RG, Gerdes AJ (1977) Optic nerve glioma: the role of radiation therapy. Cancer 40(5):2079\u20132080","journal-title":"Cancer"},{"issue":"Suppl 1","key":"383_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3171\/2016.8.GKS161432","volume":"125","author":"AM El-Shehaby","year":"2016","unstructured":"El-Shehaby AM, Reda WA, Abdel Karim KM, Emad Eldin RM, Nabeel AM (2016) Single-session Gamma Knife radiosurgery for optic pathway\/hypothalamic gliomas. J Neurosurg 125(Suppl 1):50\u201357","journal-title":"J Neurosurg"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-020-00383-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-020-00383-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-020-00383-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:02:41Z","timestamp":1744178561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-020-00383-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,24]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["383"],"URL":"https:\/\/doi.org\/10.1007\/s10014-020-00383-x","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,24]]},"assertion":[{"value":"28 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}